https://www.eventscribe.com/2017/FOCIS/agenda.asp?h=Full Schedule There will be 4 hours scientific presentation titled 'Insights into the Immunology of Chronic Fatigue Syndrome' today in Chicago, sponsored by NIH (NIAID) and featuring some of the proeminent researchers in the field. Here is further info upon finding it on the schedule: Member Society Symposia Insights into the Immunology of Chronic Fatigue Syndrome Wednesday, June 14 12:45 PM - 4:45 PM Sponsored By: Myalgic encephalomyelitis /chronic fatigue syndrome (ME/CFS) is a debilitating and complex disorder that severely impacts the life of ~2 million Americans. There is no documented cause of ME/CFS, it is difficult to diagnose, and there are no specific biomarkers nor diagnostic testing available currently. Multiple recent ME/CFS expert panels have recommended multidisciplinary, novel approaches to gain a better understanding of ME/CFS. This symposium will bring together immunologists working in the ME/CFS field to review progress of immunological studies and foster collaborations on biomarker discovery, immune mechanisms and potential therapeutic development. Chair: Joseph Breen, PhD, National Institutes of Health Program: 12:45p.m. Welcome and Objectives Joseph Breen, PhD, National Institutes of Health and Vicky Whittemore, PhD, National Institute of Neurological Disorders and Stroke 12:50 p.m. The Public Health Problem of ME/CFS Elizabeth Unger, MD, Centers for Disease Control and Prevention 1:15 p.m. Evidence of T-Cell activity in ME/CFS Mark Davis, PhD, Stanford University 1:45 p.m. Immunological characterisation of ME/CFS cases and controls from the UK ME/CFS Biobank Eleanor Riley, PhD, University of London 2:35 p.m. - Coffee break 2:55 p.m. Pathobiology of ME/CFS Ian Lipkin, MD, Columbia University 3:35 p.m. Circulating Cytokine Signatures Associated with ME/CFS Severity and Duration Jose Montoya, MD, Stanford University 4:15 p.m. Question/Answer Forum All speakers Learning Objectives: This half‐day symposium will provide a forum for experts in the immunology of ME/CFS to present the current state of the science to key clinical immunology stakeholders. These interactions should stimulate new approaches to decipher the mechanistic and immunological underpinnings of ME/CFS. Such collaborative efforts will open new research avenues and potential clinical solutions to combat ME/CFS. Footnote: I do not believe there is webcasting for this, it would be nice if it was.